The Reply to the Letter to the Editor Regarding: "The Autologous CaTeVac Dendritic Cell Vaccine in Patients With Melanoma: Final Results of the DENDRON-01 Study". Вопр. онкол. 2026, 72 (1), OF-2568. https://doi.org/10.37469/0507-3758-2026-72-1-OF-2568.